Published on: September 15, 2020
United States Pharmacopeial Convention (USP) is continuing stakeholder engagement activities to foster input pertaining to beyond-use date (BUD) provisions in the compounding general chapters, and . These activities follow a final decision on formal appeals to these chapters, which recommended further engagement by the Compounding Expert Committee (CMP EC) with stakeholders on the issues raised pertaining to BUDs.
The Open Forum session was held on September 15, 2020. This was an open event, and USP invited all who wished to participate to register for the virtual event. Participants were able to ask questions, make comments and provide recommendations for 2020 – 2025 through a virtual discussion board.
USP and the CMP EC remain committed to moving forward in an open, transparent, balanced and timely manner. For any questions, please contact the USP Healthcare Quality and Safety staff at CompoundingSL@usp.org.